RSS

personalised medicine

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

NHS England has announced a landmark deal, giving children and young people access to Novartis’ Kymriah (a chimeric antigen receptor T-cell, CAR-T, therapy) — a personalised therapy for the treatment of cancer. more

News

Deloitte and Vineti have entered into a teaming agreement for the collaborative development of end-to-end solutions to support personalised medicine. more

News

The July/August issue of EPM magazine is available for download with all the regulars and features on legal — IP, sterilisation, ACHEMA review, excipients, personalised medicine plus a drug delivery supplement. more

Latest Issue

Here, Trevor Marshall, director of global engineering at Zenith Technologies, goes into detail about how integrating and automating cell therapy production with MES will help grow the personalised medicine sector and ultimately benefit patients more

Opinion

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

According to data and analytics company, GlobalData, personalised medicine is becoming an increasing possibility for patients as a result of newly developed algorithms and the use of big data. more

Analysis

According to new research from the US, a side-effect of a common prostate cancer drug can, in some men with advanced disease who have a specific genetic variant, actually fuel cancer cells. more

News

Despite the ongoing trend in digital tech across the board, pharma is still lagging behind in unlocking the potential of these useful tools… more

Opinion

In this article, Maria Andrielou, marketing & communication, and Thanos Andreou, scientific affairs, at VIO Chemicals, give their views on how to get the best out of process R&D. more

, Opinion

Diagnostics company, Owlstone Medical, has signed a service agreement with global biopharmaceutical company, AstraZeneca, to explore how breath can be used to identify novel biomarkers for personalised medicine applications. more

News

Contract CRO, Aptus Clinical, is to be one of 12 partners to receive government funding that will be used to ensure more patients benefit from a new generation of disease-fighting medicines for cancer and non-cancer illnesses more

News

At this year’s successful pharma packaging and drug delivery exhibition and conference, Pharmapack Europe, experts highlighted forthcoming major industry trends as being personalised medicines, intelligent packaging and US FDA deadlines more

Analysis

Today, the FDA will convene the Oncologic Drugs Advisory Committee to review Novartis’ personalised cancer therapy, CTL019. The first discussion point of the meeting will focus on manufacturing and product quality control more

News

Dragon Master Foundation has announced plans to provide financial and collaborative support to a clinical trial that will make patient data available live in the cloud while the trial is underway. more

News

Global healthcare company Novo Nordisk, alongside global pharmaceutical company Pfizer, are investing $9 million into the Swedish-based digital health company AMRA. more

News

Personalised medicine is being heralded as the future. Harnessing big data in medicine yields valuable insights and advances knowledge. more

News

Opportunities for personalised medicine are becoming increasingly evident throughout the UK. The potential of personalised medicine has been recognised by the organisers of CPhI who will be looking at it as part of the Pre-Connect Congress. more

News

A team of researchers from the National University of Singapore (NUS) have found a way to 3D print personalised medicine more

Technology

So the pharma landscape continues to evolve. It’s interesting to witness the changes taking place, many of them using technology to improve the way medicine and drugs are administered, monitored and prescribed more

Opinion